Improving optical tissue clearing method for better cancer diagnosis

When it comes to cancer, clarity is key. The ability to visualize cancerous tumors and metastatic tissue three dimensionally (3D) can help clinicians diagnose the precise type and stage of cancer, while also informing the best treatment methods. To obtain an even clearer tissue for imaging, a research team based in Japan has tested the effectiveness of specialized hydrogels. Acting as a 3D molecular network, these hydrogels can rapidly remove fats from tissues, which are a factor in tissue opacification, without losing their structure. The material is used in several biomedical devices, including contact lenses.

They published their results online on June 21 in Macromolecular Bioscience with the print edition issued on Sep. 16.

Since 1981, the leading cause of death in Japan has been cancer," said first author Chie Kojima, associate professor in the Department of Applied Chemistry in the Graduate School of Engineering at Osaka Prefecture University. "We need new treatment methods and diagnostic techniques. 3D fluorescence imaging is one such approach that could prove indispensable for understanding multicellular systems on the scale of an organ, as it can give us more information than traditional 2D imaging. This could be useful for personalized medicine in diagnosis, as well as elucidating biological phenomena.

This type of imaging involves tagging certain molecular machines, such as proteins, so they fluoresce with different colors depending on what they are. The glowing signals can be viewed in a variety of samples, from whole organisms down to the cellular level. Most tissues are opaque, though, blocking the ability to see these signals. In 2D imaging, the samples are sliced thinly, which makes the signals easy to see but removes the ability to visualize the full system in 3D.

Previously, researchers have used an approach known as CLARITY, in which the tissues are embedded in polyacrylamide hydrogels. The fats are removed from the tissues and the refractive index of the media is adjusted. The tagged glowing signals can be visualized in 3D, but it takes a month for the cancerous tissue to clear -; far too long for a patient waiting for a diagnosis, according to Kojima. In that time, the tumor would have likely spread.

The optical clearing process time in the CLARITY method needs to be shortened for practical applications."

Chie Kojima, First Author

To cut this time, the researchers used zwitterionic hydrogels, which are balanced in their charged molecules and hold the structure of tissue samples. Of several zwitterionic hydrogel combinations, the team found that polymer hydrogels that mimic fatty molecules on the tissue appear to optically clear tumor tissues the quickest. According to Kojima, the hydrogels are highly osmotic, which may help pull other fatty acids from the tissue.

Blood vascular networks in murine brain tissues, as well as metastatic tumor tissues could be visualized in 3D using our system," Kojima said.

And they could visualize the tumor tissues quicker than in their previous attempts: what previously took a month could be achieved in a week with the improved approach.

The researchers are continuing to explore the technique and how to apply it for diagnosing cancer in humans.

We are attempting to apply our system for pathological diagnostics," Kojima said. "We expect that it will be possible to diagnose a whole biopsy sample -; instead of thin slices -; which could prevent the oversight of small cancers.

Source:
Journal reference:

Kojima, C., et al. (2021) Application of Zwitterionic Polymer Hydrogels to Optical Tissue Clearing for 3D Fluorescence Imaging. Macromolecular Bioscience. doi.org/10.1002/mabi.202100170.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients